Multiple Zerodha users on Monday took to social media to complain about tech glitches related to placed orders. While the broker updated that the glitch has been fixed, investors expressed their anger on social media.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,